What you’ll do:
- Demonstrate advanced knowledge of uveal melanoma, tumor biology, emerging clinical data, the competitive environment, and darovasertib’s mechanism of action.
- Independently develop and execute territory/ecosystem account strategies to drive appropriate product utilization.
- Build peer-level relationships with academic oncologists, ocular specialists, and multidisciplinary stakeholders.
- Translate complex clinical data into clear, compliant product education tailored to stakeholders.
- Execute pre-launch and launch strategies aligned with national brand objectives.
- Identify, activate, and optimize referral networks across the patient journey.
- Partner with Medical Affairs, Value & Access, and Patient Services to support complex accounts.
- Use analytics/performance data to optimize resource deployment, account prioritization, and execution plans.
- Complete administrative requirements (budget, expenses, CRM reporting).
- Ensure promotional activities adhere to regulatory/ethical standards.
- Travel: ~80%.
Requirements:
- Bachelor’s degree in business, biological sciences, or related.
- 10+ years pharmaceutical sales; 5+ years oncology sales.
- Proven success launching a first-in-class or specialty oncology product in the US.
- Rare disease/orphan oncology/highly specialized market experience strongly preferred.
- Ability to engage in high-level scientific dialogue with academic HCPs.
- Reimbursement process knowledge and experience supporting patient access.
- Proven track record managing complex academic and community oncology accounts.
- Strong analytics, planning, and organization; autonomy/accountability/professionalism.
- Overnight travel; residence within assigned geographic region.
Total Rewards:
- Expected salary range: $187,000–$231,000.
- Benefits include medical/dental/vision (100% employee; 90% dependents), 401k, ESPP, and wellness programs.